世界の特殊検査市場は、2021年の262億ドルから2031年までに884億ドルを超える見込みで、予測期間中のCAGRは13%と推定されます。慢性、感染性、希少遺伝性疾患の発生率の上昇、酵素結合免疫吸着検定法 (ELISA) およびリアルタイムポリメラーゼ連鎖反応 (RT-PCR) に対する需要の増加が、市場を押し上げています。さらに、市場は、難解な検査のための技術的進歩だけでなく、診断サービスセンターに対する民間および政府機関からの融資の増加からも恩恵を受ける可能性があります。
目次
1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Esoteric Testing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 Market Characteristics
3.1. Market Definition
3.2. Esoteric Testing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 Esoteric Testing Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 Macroeconomic Indicators
6 Recent Developments
7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 Risk Analysis
9 Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 Esoteric Testing Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 Esoteric Testing Market Size & Forecast 2021A-2031F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Infectious Diseases Testing
11.3.1.1.1. By Value (USD Million) 2021-2031F
11.3.1.1.2. Market Share (%) 2021-2031F
11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.2. Endocrinology Testing
11.3.1.2.1. By Value (USD Million) 2021-2031F
11.3.1.2.2. Market Share (%) 2021-2031F
11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.3. Oncology Testing
11.3.1.3.1. By Value (USD Million) 2021-2031F
11.3.1.3.2. Market Share (%) 2021-2031F
11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.4. Genetics Testing
11.3.1.4.1. By Value (USD Million) 2021-2031F
11.3.1.4.2. Market Share (%) 2021-2031F
11.3.1.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.5. Toxicology Testing
11.3.1.5.1. By Value (USD Million) 2021-2031F
11.3.1.5.2. Market Share (%) 2021-2031F
11.3.1.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.6. Immunology Testing
11.3.1.6.1. By Value (USD Million) 2021-2031F
11.3.1.6.2. Market Share (%) 2021-2031F
11.3.1.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.7. Neurology Testing
11.3.1.7.1. By Value (USD Million) 2021-2031F
11.3.1.7.2. Market Share (%) 2021-2031F
11.3.1.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.8. Other Testing
11.3.1.8.1. By Value (USD Million) 2021-2031F
11.3.1.8.2. Market Share (%) 2021-2031F
11.3.1.8.3. Y-o-Y Growth (%) 2021-2031F
11.3.2. By Technology
11.3.2.1. Chemiluminescence Immunoassay
11.3.2.1.1. By Value (USD Million) 2021-2031F
11.3.2.1.2. Market Share (%) 2021-2031F
11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.2. Enzyme-Linked Immunosorbent Assay
11.3.2.2.1. By Value (USD Million) 2021-2031F
11.3.2.2.2. Market Share (%) 2021-2031F
11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.3. Mass Spectrometry
11.3.2.3.1. By Value (USD Million) 2021-2031F
11.3.2.3.2. Market Share (%) 2021-2031F
11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.4. Real-Time PCR
11.3.2.4.1. By Value (USD Million) 2021-2031F
11.3.2.4.2. Market Share (%) 2021-2031F
11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.5. DNA Sequencing
11.3.2.5.1. By Value (USD Million) 2021-2031F
11.3.2.5.2. Market Share (%) 2021-2031F
11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.6. Flow Cytometry
11.3.2.6.1. By Value (USD Million) 2021-2031F
11.3.2.6.2. Market Share (%) 2021-2031F
11.3.2.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.7. Other Technologies
11.3.2.7.1. By Value (USD Million) 2021-2031F
11.3.2.7.2. Market Share (%) 2021-2031F
11.3.2.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.3. By End User
11.3.3.1. Independent & Reference Laboratories
11.3.3.1.1. By Value (USD Million) 2021-2031F
11.3.3.1.2. Market Share (%) 2021-2031F
11.3.3.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.3.2. Hospital-Based Laboratories
11.3.3.2.1. By Value (USD Million) 2021-2031F
11.3.3.2.2. Market Share (%) 2021-2031F
11.3.3.2.3. Y-o-Y Growth (%) 2021-2031F
12 North America Esoteric Testing Market Size & Forecast 2021A-2031F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Technology
12.3.3. By End User
12.3.4. Country
12.3.5. United States
12.3.6. Canada
13 Europe Esoteric Testing Market Size & Forecast 2021A-2031F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Technology
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 Asia Esoteric Testing Market Size & Forecast 2021A-2031F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Technology
14.3.3. By End User
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 Middle East and Africa Esoteric Testing Market Size & Forecast 2021A-2031F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Technology
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 Latin America Esoteric Testing Market Size & Forecast 2021A-2031F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2. By Technology
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 Company Profiles
18.1. ARUP Laboratories
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Baylor Esoteric and Molecular Laboratory
18.3. Foundation Medicine
18.4. Healius Limited
18.5. Laboratory Corporation
18.6. Mayo Foundation for Medical Education and Research
18.7. OPKO Health
18.8. Quest Diagnostics
18.9. Sonic Healthcare Limited
18.10. Stanford Clinical Pathology
18.11. Other Prominent Players
19 Appendix
20 Consultant Recommendation
